Clinical Trial

Aerobic Exercise and Resistant Hypertension

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 18, 2025 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study will examine the effects of 4 months of aerobic interval training versus continuous aerobic training on ambulatory blood pressure (ABP) and novel plasma protein biomarkers in patients with resistant hypertension. A randomized controlled trial will be performed including two exercise groups and a control group: a) moderate-intensity interval training (MIIT); b) moderate-intensity continuous training (MICT); c) usual care. MIIT could represent a superior training modality that exceeds the benefits of MICT in patients with resistant hypertension.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-09-30; most recent amendment 2025-09-12.
Status change: Recruiting → Active, Not Recruiting 2025-04-22
Status change: Not Yet Recruiting → Recruiting 2022-10-05
Trial Details
NCT Number NCT05563077
Lead Sponsor Universidad Europea de Madrid
Conditions Resistant Hypertension
Enrollment 72 participants
Start Date 2022-10-05
Primary Completion 2025-11-01 (estimated)
Study Completion 2025-11-15 (estimated)
Updated on ClinicalTrials.gov 2025-09-18